Changgeng Qian
CIK 1402196 · View on SEC EDGAR ↗
First SEC filing: June 8, 2007 · Latest: June 8, 2007
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Jan. 7, 2011 | CRIS | A | 31,508 | — | — | 31,508 Direct | — | Acquired | (price as of 2026-08-21) |
| Jan. 7, 2011 | CRIS | A | 93,492 | — | — | 93,492 Direct | — | Acquired | (price as of 2026-08-21) |
| Feb. 2, 2010 | CRIS | A | 39,063 | — | — | 39,063 Direct | — | Acquired | (price as of 2026-08-21) |
| Feb. 2, 2010 | CRIS | A | 85,937 | — | — | 85,937 Direct | — | Acquired | (price as of 2026-08-21) |
| Feb. 5, 2009 | CRIS | A | 159,790 | — | — | 159,790 Direct | — | Acquired | (price as of 2026-08-21) |
| Feb. 5, 2009 | CRIS | A | 20,210 | — | — | 20,210 Direct | — | Acquired | (price as of 2026-08-21) |
| Feb. 5, 2009 | CRIS | A | 159,790 | — | — | 159,790 Direct | — | Acquired | (price as of 2026-08-21) |
| Feb. 5, 2009 | CRIS | A | 20,210 | — | — | 20,210 Direct | — | Acquired | (price as of 2026-08-21) |
| Oct. 24, 2008 | CRIS | A | 51,000 | $0.79 | $40,290 | 51,000 Direct | — | Acquired | -99.9% (price as of 2026-08-21) |
| Jan. 25, 2008 | CRIS | A | 124,925 | — | — | 124,925 Direct | — | Acquired | (price as of 2026-08-21) |
| Jan. 25, 2008 | CRIS | A | 55,075 | — | — | 55,075 Direct | — | Acquired | (price as of 2026-08-21) |
| June 6, 2007 | CRIS | A | 78,058 | — | — | 78,058 Direct | — | Acquired | (price as of 2026-08-21) |
| June 6, 2007 | CRIS | A | 71,942 | — | — | 71,942 Direct | — | Acquired | (price as of 2026-08-21) |
| June 6, 2007 | CRIS | A | 70,233 | — | — | 70,233 Direct | — | Acquired | (price as of 2026-08-21) |
| June 6, 2007 | CRIS | A | 79,767 | — | — | 79,767 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 7, 2011 | CRIS | Non-qualified stock option (right to buy) | Common stock (31,508) | $2.15 | Jan. 7, 2021 | 31,508 | Acquired |
| Jan. 7, 2011 | CRIS | Qualified stock option (right to buy) | Common stock (93,492) | $2.15 | Jan. 7, 2021 | 93,492 | Acquired |
| Feb. 2, 2010 | CRIS | Qualified stock option (right to buy) | Common stock (39,063) | $2.27 | Feb. 2, 2020 | 39,063 | Acquired |
| Feb. 2, 2010 | CRIS | Non-qualified stock option (right to buy) | Common stock (85,937) | $2.27 | Feb. 2, 2020 | 85,937 | Acquired |
| Feb. 5, 2009 | CRIS | Non-qualified stock option (right to buy) | Common stock (159,790) | $1.07 | Feb. 5, 2019 | 159,790 | Acquired |
| Feb. 5, 2009 | CRIS | Qualified stock option (right to buy) | Common stock (20,210) | $1.07 | Feb. 5, 2019 | 20,210 | Acquired |
| Feb. 5, 2009 | CRIS | Non-qualified stock option (right to buy) | Common stock (159,790) | $1.07 | Feb. 5, 2019 | 159,790 | Acquired |
| Feb. 5, 2009 | CRIS | Qualified stock option (right to buy) | Common stock (20,210) | $1.07 | Feb. 5, 2019 | 20,210 | Acquired |
| Oct. 24, 2008 | CRIS | Non-qualified stock option (right to buy) | Common stock (51,000) | $0.79 | Oct. 24, 2018 | 51,000 | Acquired |
| Jan. 25, 2008 | CRIS | Non-qualified stock option (right to buy) | Common stock (124,925) | $1.43 | Jan. 25, 2018 | 124,925 | Acquired |
| Jan. 25, 2008 | CRIS | Qualified stock option (right to buy) | Common stock (55,075) | $1.43 | Jan. 25, 2018 | 55,075 | Acquired |
| June 6, 2007 | CRIS | Non-qualified stock option (right to buy) | Common stock (78,058) | $1.39 | June 6, 2017 | 78,058 | Acquired |
| June 6, 2007 | CRIS | Qualified stock option (right to buy) | Common stock (71,942) | $1.39 | June 6, 2017 | 71,942 | Acquired |
| June 6, 2007 | CRIS | Non-qualified stock option (right to buy) | Common stock (70,233) | $1.39 | June 6, 2017 | 70,233 | Acquired |
| June 6, 2007 | CRIS | Qualified stock option (right to buy) | Common stock (79,767) | $1.39 | June 6, 2017 | 79,767 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 14 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| June 8, 2007 | CRIS | Common Stock [F8] | 5,014 | Direct |
| June 8, 2007 | CRIS | Qualified stock option (right to buy)→ Common stock (20,000) | 20,000 | Direct |
| June 8, 2007 | CRIS | Qualified stock option (right to buy)→ Common stock (10,125) | 10,125 | Direct |
| June 8, 2007 | CRIS | Qualified stock option (right to buy)→ Common stock (9,375) | 9,375 | Direct |
| June 8, 2007 | CRIS | Qualified stock option (right to buy)→ Common stock (35,000) | 35,000 | Direct |
| June 8, 2007 | CRIS | Qualified stock option (right to buy)→ Common stock (24,000) | 24,000 | Direct |
| June 8, 2007 | CRIS | Qualified stock option (right to buy)→ Common stock (24,000) | 24,000 | Direct |
| June 8, 2007 | CRIS | Qualified stock option (right to buy)→ Common stock (15,136) | 15,136 | Direct |
| June 8, 2007 | CRIS | Qualified stock option (right to buy)→ Common stock (20,000) | 20,000 | Direct |
| June 8, 2007 | CRIS | Qualified stock option (right to buy)→ Common stock (53,253) | 53,253 | Direct |
| June 8, 2007 | CRIS | Non-qualified stock option (right to buy)→ Common stock (864) | 864 | Direct |
| June 8, 2007 | CRIS | Non-qualified stock option (right to buy)→ Common stock (20,000) | 20,000 | Direct |
| June 8, 2007 | CRIS | Non-qualified stock option (right to buy)→ Common stock (46,747) | 46,747 | Direct |
| June 8, 2007 | CRIS | Qualified stock option (right to buy)→ Common stock (10,000) | 10,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
CRIS
President, Research and Preclinical Development| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2011 | — | — | — | — | — | — | — | — |
| 2010 | — | — | — | — | — | — | — | — |
| 2009 | — | — | — | — | — | — | — | — |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.